Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - LONG-TERM DEBT
Long-term Debt HALO - Halozyme Therapeutics, Inc.
1.51 B
LAST VALUE
-0.65%
2 YEAR CAGR
31.21%
5 YEAR CAGR
40.61%
10 YEAR CAGR